The Melbourne ASSET Score: Prospective Validation and Impact
- Project status: Active
Research area: Infection, Immunity and Global Health > Clinical Infections
The Melbourne ASSET score was designed to help clinicians decide whether to use intravenous (IV) or oral antibiotics for children with skin and soft tissue infection.
Overview
Skin infections are very common in children. In most cases, children can be treated with antibiotics taken by mouth but in some children, clinicians might choose to give antibiotics through a vein, known as IV or drip antibiotics.
There is a scoring system that helps clinicians decide whether to use antibiotics by mouth or IV, called the ASSET score. We want to see how well the ASSET score works and whether doctors and nurses in the Emergency find the score useful.
Information for participants and families
We want to know whether your child’s skin infection improved (or not) from the treatment prescribed at the time of the Emergency Department (ED) visit. The research team will send you a text message three days after your ED visit to ask how your child is doing and then a week later to see if the skin infection is all better.
Research team
- Dr Laila Ibrahim, Murdoch Children's Research Institute, The Royal Children’s Hospital
- Dr Ailbhe McGrath, The Royal Children’s Hospital
- Dr Sarah Donoghue, The Royal Children’s Hospital
- Dr Leila Ahmed, The Royal Children’s Hospital
Funding
ASSET is sponsored by Murdoch Children’s Research Institute (MCRI).
Contact us
The Melbourne ASSET Score: Prospective Validation and Impact
Murdoch Children's Research Institute
The Royal Children's Hospital
50 Flemington Road
Parkville VIC 3052
Australia
Email: show email address